Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2021 | 03-2021 | 02-2021 | 11-2020 | 08-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,414 | N/A | 33,805 | 14,931 | 19,296 |
| Marketable Securities | 12,227 | N/A | 22,984 | 19,417 | 20,604 |
| TOTAL | $72,233 | $N/A | $57,472 | $36,024 | $40,511 |
| Non-Current Assets | |||||
| PPE Net | 389 | N/A | 415 | 409 | 99 |
| Investments And Advances | 7,290 | 0 | 3,142 | 3,880 | 3,930 |
| Other Non-Current Assets | 580 | 0 | 628 | 658 | 93 |
| TOTAL | $8,259 | $N/A | $4,185 | $4,947 | $4,122 |
| Total Assets | $80,492 | $N/A | $61,657 | $40,971 | $44,633 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,918 | 0 | 3,090 | 2,901 | 1,789 |
| TOTAL | $5,750 | $N/A | $5,932 | $5,742 | $4,536 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,703 | N/A | 2,703 | 2,703 | 2,703 |
| Other Non-Current Liabilities | 1,040 | 393 | 677 | 744 | 271 |
| TOTAL | $5,547 | $N/A | $6,283 | $7,017 | $7,218 |
| Total Liabilities | $11,297 | $N/A | $12,215 | $12,759 | $11,754 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,514 | N/A | 30,228 | 26,661 | N/A |
| Common Shares | 366 | N/A | 339 | 286 | 284 |
| Retained earnings | -107,999 | N/A | -102,792 | -98,184 | -92,614 |
| Other shareholders' equity | 1,077 | 0 | 0 | 0 | 0 |
| TOTAL | $69,195 | $N/A | $49,442 | $28,212 | $32,879 |
| Total Liabilities And Equity | $80,492 | $0 | $61,657 | $40,971 | $44,633 |